A patient enrolled in a long-term study of Pfizer's hemophilia drug Hympavzi died after experiencing serious side effects, ...

Hempazzi, which is administered as a once-weekly injection, received US regulatory approval last year for the prevention or ...

A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing ...

The patient, who died on December 14, was originally enrolled in a Phase III study in 2022 and transitioned into an extension phase in 2023.

The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli ...

With thousands of lawsuits and growing concerns over long-term risks, the FDA have added brain tumor warning to the label.

Depo Provera’s label change comes amidst a flurry of over 2,000 lawsuits from women alleging that the contraceptive caused ...

The action follows mounting scientific evidence linking the injectable contraceptive medication to an increased risk for meningioma.

The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot ...

The pharma giant announced that the Food and Drug Administration approved its new safety warning label for Depo-Provera — Pfizer’s birth control injection that has been a subject of controversy as ...